We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Trestle and Bacus Integrate Systems

By Labmedica staff writers
Posted on 01 Jul 2005
In a move designed to provide pathologists with more options, Trestle Holdings, Inc. More...
(Irvine, CA, USA) has partnered with Bacus Laboratories, Inc. (Chicago, IL, USA) to integrate the advanced digital microscope systems of Bacus with Trestle's suite of digital pathology workflow applications.

This agreement allows pathologists to use Trestle's Xcellerator application suite and connect it to a wider choice of digital microscopy devices. This integration marks a move away from proprietary formats, toward technical standards and open architecture intended to benefit users who have often been frustrated by the lack of interoperability among software and hardware. Bacus' viewing format offers compatibility with the microscopes used in the Nikon Coolscope VS systems as well as with Trestle's MedMicro products.

"As pathologists embrace digital devices and workflow applications, it is essential that the industry respond with improved plug-and-play compatibility so that users can derive more value from their investments in equipment,” stated Maurizio Vecchione, CEO of Trestle Holdings. "Now, pathologists can choose the optimal device for specialized forms of imaging and integrate their virtual microscopy data into one, consistent, standardized digital workflow solution.” Trestle Holdings develops and sells digital imaging and telemedicine products that link dispersed users with each other via information databases and analytical tools.

"There is now a recognized need to organize virtual slides in a meaningful and flexible way for storage and subsequent review by multiple parties,” observed Dr. James Bacus, president of Bacus Laboratories. "This agreement will allow both companies to focus on their respective areas of expertise.”





Related Links:
Trestle Holdings
Bacus Laboratories

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.